Literature DB >> 7058767

Hemodynamic and gas exchange effects of intravenous diltiazem in patients with pulmonary hypertension.

B J Crevey, D R Dantzker, J S Bower, K D Popat, S D Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7058767     DOI： 10.1016/s0002-9149(82)80015-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  10 in total

1.  Primary pulmonary hypertension.

Authors:  T Higenbottam
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

Review 2.  Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

Authors:  M M Buckley; S M Grant; K L Goa; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  Usefulness of diltiazem in the acute management of supraventricular tachyarrhythmias in the elderly.

Authors:  A Millaire; O Leroy; P de Groote; C Santré; G Ducloux
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

4.  Management of primary pulmonary hypertension.

Authors:  C M Oakley
Journal:  Br Heart J       Date:  1985-01

Review 5.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

Review 6.  Drug treatment of primary pulmonary hypertension.

Authors:  A A McLeod; D E Jewitt
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

7.  Effects of verapamil on pulmonary haemodynamics during hypoxaemia, at rest, and during exercise in patients with chronic obstructive pulmonary disease.

Authors:  S E Brown; G S Linden; R R King; G P Blair; D W Stansbury; R W Light
Journal:  Thorax       Date:  1983-11       Impact factor: 9.139

Review 8.  Calcium antagonists. Pharmacodynamic effects and mechanism of action.

Authors:  T T Zsotér; J G Church
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

Review 9.  Calcium channel blockers for pulmonary arterial hypertension.

Authors:  Zhiyu Fan; Yuanjing Chen; Hanmin Liu
Journal:  Cochrane Database Syst Rev       Date:  2015-09-25

Review 10.  Epoprostenol sodium for treatment of pulmonary arterial hypertension.

Authors:  Yukihiro Saito; Kazufumi Nakamura; Satoshi Akagi; Toshihiro Sarashina; Kentaro Ejiri; Aya Miura; Aiko Ogawa; Hiromi Matsubara; Hiroshi Ito
Journal:  Vasc Health Risk Manag       Date:  2015-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.